Skip to main content

Advertisement

Table 3 Clinical and Amplicor result status comparison between baseline and follow-up for children present at both time-points

From: Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal

  Active trachoma (TF and/or TI) Amplicor-negative at both time-points Amplicor-positive at both time-points Amplicor-positive at baseline only Amplicor-positive at follow-up only Total
The Gambia No active trachoma at either time-point 552 0 6 13 571
Active trachoma at both time-points 68 6 1 7 82
Active trachoma at baseline only 114 0 13 1 128
Active trachoma at follow-up only 58 1 1 6 66
Total 792 7 21 27 847
Senegal No active trachoma at either time-point 995 0 4 14 1013
Active trachoma at both time-points 38 5 1 9 53
Active trachoma at baseline only 141 0 16 0 157
Active trachoma at follow-up only 39 0 0 20 59
Total 1213 5 21 43 1282